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Abstract. Endogenous opioid peptides are thought to play 
a role in mediating the palatability or rewarding aspects 
of sweet tastes. There is also evidence, however, which sug- 
gests that opioids may influence the preference for the taste 
of salt as well. In the present studies, we measured the 
effects of  central administration of naloxone and the mu 
agonist [D-Ala2,MePhe4,Gly-olS]enkephatin (DAGO) on 
the ingestion of salt solutions. In non-deprived rats given 
a choice of water and 0.6% saline, ICV injections of DAGO 
(1 and 3 nmol) significantly increased the intake of 0.6% 
saline; baseline water intake was minimal and was unaf- 
fected by DAGO. When rats were given a choice between 
water and 1.7% saline, DAGO stimulated both water and 
saline intake. Because 1.7% saline is a hypertonic solution, 
the increase in water intake may have been secondary to 
saline intake. In rats on a deprivation schedule in which 
water and 0.6% saline were available for only ~ 3  h/day, 
there was a tendency for DAGO to increase 0.6% saline 
intake and decrease water intake, though these effects were 
not significant. In rats given water and 1.7% saline, DAGO 
increased saline intake and had no effect on water intake. 
Natoxone was also tested in water-deprived rats. Naloxone 
(20 and 50 gg) significantly decreased 0.6% saline intake; 
baseline water intake was low (3-5 ml) and was unaffected 
by naloxone. When rats were given a choice between water 
and 1.7% saline, naloxone (50 pg) significantly reduced 
water intake, while intake of 1.7% saline was slightly in- 
creased. These results suggest a role for central mu opioid 
receptors in mediating the preference for salt solutions. 
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A number of studies have implicated endogenous opioid 
systems in the mediation of the palatability or reward value 
of food (LeMagnen et al. 1980; Calcagnetti and Reid 1983; 
Cooper 1983; Siviy and Reid 1983; Reid 1985; Czirr and 
Reid 1986; Lynch 1986; Cooper et al. 1988). These studies 
have dealt primarily with the effects of  opioid agonists and 
antagonists on the intake of sweet-tasting liquids, such as 
sucrose, glucose and saccharin solutions. However, a few 
studies indicate that opioids may also be involved in the 
preference or rewarding aspects of  other, non-sweet tasting 
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fluids, such as salt and alcohol solutions (Cooper and Gil- 
bert 1984; Kuta et al. 1984; Bertino et al. 1988; Wild et al. 
1988). Cooper and Gilbert (1984) found that when rats 
were given simultaneous access to water and a hypotonic 
saline solution, naloxone caused a selective reduction in 
the intake of the saline solution. In experiments in which 
rats were given only one liquid (water, saccharin or saline 
solution), naloxone abolished the initial increased consump- 
tion of saline (Cooper and Turkish 1983). Both naloxone 
and the opioid antagonist Mr2266 reduced saline intake 
at lower doses than those required to reduce water intake 
(Levine et al. 1982; Ukai et al. 1988). In mice, Kuta et al. 
(1984) reported that naloxone reduced the intake of a 1.5% 
saline solution induced by immobilization stress, food de- 
privation, or the injection of angiotensin II. These studies 
suggest the possibility that an interaction exists between 
endogenous opioid systems and the preference for salt solu- 
tions. 
As might be predicted from the effect of antagonists, 
the mu agonist morphine was found to increase intake of 
or preference for salt solutions. Bertino et al. (1988) found 
that in 1 h drinking tests with water-deprived rats, systemic 
injections of  morphine increased rats' preference for 
isotonic (0.9%) saline. In mice, morphine increased prefer- 
ence for 3.0% saline over water; preferences for 0.75 and 
1.5% saline were not affected (Kuta et al. 1984). 
Much evidence suggests that the effects of opioid ago- 
nists and antagonists on food and water intake are centrally 
mediated (see Levine et al. 1985; Gosnelt 1987). Therefore, 
in the experiments reported here we measured saline and 
water intake after central injections of naloxone and [D- 
Ala2,MePhe~,Gly-olS]enkephalin (DAGO), a selective ago- 
nist at mu opioid receptors (Handa et al. 1981). Because 
the direction of the effect of some opioid agonists depends 
on the deprivation status of the animals (Sanger and 
McCarthy 1980; Turkish and Cooper 1984), we tested 
DAGO in non-deprived as well as deprived rats. These stu- 
dies were designed to determine whether the effects of  selec- 
tive agonists delivered directly into the brain are similar 
to those observed after systemic administration of mor- 
phine. 
Materials and methods 
Animals and surgery. Male Sprague-Dawley rats, obtained 
from Charles River Laboratories, Inc. (Wilmington, MA), 
were used in all experiments. At the time of surgery, body 
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weights ranged from 243 to 304 g. They were individually 
housed in stainless steel cages, and food and water were 
available ad tibitum except as described below. Lights were 
on for 12 h daily (on at 0700 hours), and all experiments 
were carried out in the light period. Under sodium pento- 
barbital anesthesia (40-50 mg/kg), a 20 gauge cannula was 
implanted into the fight lateral ventricle of each rat with 
techniques similar to those previously reported (Gosnell 
et al. 1987). With the incisor bar set at 3.3 mm below the 
interaural line, the cannula was placed 1.0 mm posterior 
and 1.5 mm lateral to bregma and 3.5-4.5 mm below the 
skull surface. Cannula placement was verified behaviorally 
by the observation of a drinking response to an ICV injec- 
tion of angiotensin II (AII, 100 ng). AII was injected prior 
to the start of training sessions and at the completion of 
drug testing, and only those rats which drank 5 ml or more 
of water in the 30 min following injection were included 
in data analyses. 
Salt training sessions. At least 2 days after surgery, rats 
were deprived of water overnight. The next day at 1300 
hours, they were moved to novel individual test cages with 
no food or water. One hour after being placed in these 
cages, two 25 ml graduated burets fitted with stainless steel 
sipper tubes were attached to the front of each cage, For 
approximately one-half of the rats, one buret contained 
water and the other, 0.6% sodium chloride solution (saline) 
(w/v); the remaining rats received water and 1.7% saline 
solution. They were allowed 2 h of access to these liquids, 
after which they were returned to their home cages. Water 
was not available in the home cages; food was available 
in the home cages but not the test cages. This procedure 
was repeated daily for 9 additional days. Each rat was given 
the same saline concentration throughout the entire experi- 
ment. Positions of the water and saline burets were reversed 
daily to prevent the formation of position preferences. To 
prevent rats from simply drinking indiscriminately from the 
first buret placed on the cage, a "forced sampling" tech- 
nique was used (Calcagnetti and Reid 1983; Siviy and Reid 
1983). First, one buret was placed on the cage. After the 
rat had taken a few licks at the spout, this buret was re- 
moved and the other buret was put in place. After a few 
licks at the second solution, the buret was removed, after 
which both burets were replaced simultaneously. This pro- 
cedure was omitted if a rat did not immediately begin to 
drink. 
Test procedures. After 10 training days on the deprivation 
schedule, the intakes of water and saline solutions were 
measured after ICV injections of the opioid antagonist na- 
loxone hydrochloride (Sigma Chemical Co., St. Louis, 
MO). On the 1 st test day, rats in both saline concentration 
groups (0.6 or 1.7%) were given ICV injections of 0, 20 
or 50 ~tg (0, 55 and 138 nmol) naloxone in a 5 1~1 volume. 
Naloxone was dissolved in water (HPLC grade), which was 
also used as the control injection. Injections were made 
with a 24 gauge injector which extended 1.0 mm beyond 
the tip of the guide cannula. Injections were given 45 rain 
after placement into the test cages, and burets were placed 
on the cages 15 rain after injection. On test days, rats were 
given 3 h access to saline and water, after which they were 
returned to their home cages. Saline and water intakes were 
measured every hour, and burets were refilled as needed. 
The test procedure was repeated two additional times, such 
that every rat was tested with placebo and with both doses 
of naloxone. Test days were 2 days apart, and a normal 
2 h training session was given on the intervening days (no 
injections). Injection orders for testing the three doses were 
counterbalanced, and every dose was tested in at least one 
rat on each of the three test days. 
As mentioned above, data from a given rat were ex- 
cluded if a drinking response to AII was not observed both 
before training and after drug trials. Because this verifica- 
tion procedure excluded more animals than expected, addi- 
tional rats were tested with methods similar to those de- 
scribed above. One minor exception was that these rats 
were given 1 day of training with only salt solutions avail- 
able before 10 days of training days with both fluids. Data 
from these rats were similar to those from the original ex- 
periment and were therefore pooled to bring the group size 
to n=11 for the 0.6% saline concentration and to n=10 
for the 1.7% concentration. 
Initially, cumulative intake data were analyzed at each 
measurement (1, 2 and 3 h) with a three-factor analysis 
of variance (ANOVA): dose (3 levels) x fluid (water versus 
saline) x concentration (2 levels). Because a significant con- 
centration x fluid interaction was obtained in every case, 
subsequent two-factor ANOVAs (dose x fluid) were per- 
formed considering each concentration separately. For each 
fluid, Dunnett's test (two-tailed) was then used at each mea- 
surement to compare saline and water intake in each nalox- 
one condition to the control (water injection) condition. 
Experiment 2 was designed to test the effects on saline 
intake of [D-AlaZ,MePhe4,Gly-olS]enkephalin (DAGO), a 
selective agonist at mu opioid receptors (Handa et al. 1981). 
A separate group of animals was cannulated and trained 
to drink saline in a manner similar to that described above, 
with two exceptions: rats were transferred to test cages at 
0800 hours each day, and injections were given at the time 
of transferral to the test cages (1 h before access to water 
and saline solutions). DAGO (Sigma Chemical Co., St. 
Louis, MO) was dissolved in 0.9% saline and was tested 
at doses of 0 (saline), I and 3 nmol. These doses were chosen 
because they are in or below the range of doses which stimu- 
late food intake (Gosnelt et al. 1986, 1987 and unpublished 
observations). The l-h delay between injections and fluid 
access was imposed because in previous studies, we have 
found that DAGO in this dose range produces a cataleptic 
state which dissipates within an hour. 
In experiment 3, the effects of DAGO on water and 
saline intake were tested in non-deprived rats. These ani- 
mals were cannulated and trained in a manner identical 
to that in experiment 2, with the exception that water was 
returned to the home cages after the first training session, 
and was available throughout the remainder of the experi- 
ment (except during the 1st hour in the test cages each 
day). In the first training session, only salt solutions were 
presented; in ten additional daily sessions, both water and 
salt solutions were available. The purpose of the deprivation 
prior to the first training session was to force the rats to 
sample the novel saline solutions. As was the case for exper- 
iment 1, the cannula verification procedure excluded more 
rats from the 1.7% saline group than expected. Therefore, 
additional rats were tested with similar procedures to bring 
the final group sizes to n = 9  for the 0.6% saline group 
and to n = 8 for the 1.7% saline group. In this experiment, 
it was known that baseline intakes of both water and saline 
would be minimal. Therefore, one-tailed tests (Dunnett's) 
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were used to compare the drug conditions to the placebo 
condition. 
R e s u l t s  
In deprived rats receiving water and 0.6% saline, naloxone 
decreased intake of the saline solution only (Fig. 1). At 
1, 2 and 3 h, there were significant effects of  dose [F(2,20)= 
9.08, 5.05 and 5.27] and fluid [F(1,10)=55.83, 88.57 and 
87.55, all P's < 0.05]. The dose x fluid interaction was signif- 
icant at 1 and 3 h [F(2,20)=6.10 and 3.94, P<0.05] and 
approached significance at 2 h ( P =  0.064). Both doses (20 
and 50 gg) decreased 1 h saline intake; intake remained de- 
pressed for the entire 3-h period following the 50 gg dose. 
Mean water intake was low (3.7-4.9 ml) and was not af- 
fected by naloxone. Saline preference (saline intake ex- 
pressed as a percentage of total fluid intake) was not signifi- 
cantly affected at any measurement. In the 1 st hour, prefer- 
ences for saline were 89, 81 and 74% for the 0, 20 and 
50 gg doses, respectively. 
The effect of  naloxone on intake in rats given water 
and 1.7% saline were generally reversed compared to rats 
given 0.6% saline. Water intake was greater than 1.7% 
saline intake, and was reduced by naloxone. On the other 
hand, saline intake was unchanged or increased. The 50 ~tg 
dose decreased water intake at 1 and 2 h and significantly 
increased 3-h NaC1 intake. Intakes after the 20 gg dose 
were in the same direction but were not statistically reliable 
(Dunnett 's test, two-tailed). The dose factor was significant 
only at 1 h [F(2,18)=3.78, P<0.05]. At 1, 2 and 3 h, there 
were significant fluid effects [F(1,9)=211.03, 199.74 and 
125.22] and significant dose x fluid interactions [F(2,18)= 
4.62, 9.59 and 5.22, all P's<0.05]. Saline preference was 
not significantly affected in the 1st hour (15, 24 and 17% 
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Fig. 1. Cumulative intake of water and saline solutions following 
tCV injections of  naloxone (mean+SEM).  All rats were tested 
during maintenance on a water deprivation schedule, and each 
rat was tested with all doses. Top: Rats were given access to both 
water and 0.6% NaC1 ( n = l l ) .  Bottom: Rats were given access 
to both water and 1.7% NaCI (n = I0). Asterisks indicate significant 
differences from the corresponding 0 nmot (water) condition ( P <  
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Fig. 2. Cumulative intake of water and saline solutions following 
ICV injections of  the mu agonist DAGO (mean+SEM).  All rats 
were tested during maintenance on a water deprivation schedule, 
and each rat was tested with all doses. Top: Rats were given access 
to both water and 0.6% NaC1 ( n = l l ) .  Bottom: Rats were given 
access to both water and 1.7% NaC1 (n=8).  Asterisks indicate 
significant increases above the corresponding 0 nmol (saline) condi- 
tion ( P <  0.05, two-tailed Dunnetrs  test) 
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for the 0, 20 and 50 gg doses, respectively). Based on 2- 
and 3-h cumulative intakes, both doses of naloxone signifi- 
cantly increased 1.7% saline preference (18, 27 and 27% 
for the 0, 20 and 50 gg doses at 2 h). 
In deprived rats given water and 0.6% NaC1, DAGO 
(3 nmol) tended to decrease intake in the 1st hour; thereaf- 
ter, both doses tended to decrease cumulative water intake 
and increase saline intake (Fig. 2). None of these effects, 
however, were statistically reliable (two-tailed Dunnett's 
test, all P's>0.05). In a two-factor ANOVA, there was 
a significant fluid effect at 1, 2 and 3 h [F(1,10)=24.18, 
33.93 and 29.29, all P's<0.05]. At I h, there was also a 
significant dose effect [F(2,20)= 4.35], which is due primar- 
ily to the large difference between the 1 and 3 nmol treat- 
ment conditions. Mean preference for 0.6% saline was 
sIightly increased by DAGO (at 2 h, 73, 81 and 82% for 
the 0, I and 3 nmol treatments, respectively), but these in- 
creases were not significant. 
In deprived rats given water and 1.7% saline, both doses 
of DAGO (1 and 3 nmol) increased 2-h cumulative saline 
intake; 3-h intake was increased only in the 3 nmol condi- 
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Fig. 3. Cumulative intake of water and saline solutions following 
ICV injections of the mu agonist DAGO (mean + SEM). All rats 
were tested in the non-deprived condition, and each rat was tested 
with all doses. Top: Rats were given access to both water and 
0.6% NaC1 (n= 11). Bottom: Rats were given access to both water 
and 1.7% NaC1 (n=8). Asterisks indicate significant increases 
above the corresponding 0 nmol (saline) condition (P<0.05, one- 
tailed Dunnett's test) 
tion. Water intake was not significantly affected at any 
point. There was a significant fluid effect at 1, 2 and 3 h 
[F(1,7)=38.76, 31.77 and 31.33] and a significant dose x 
fluid interaction at 1 and 2 h [F(2,14)=3.84 and 5.45, all 
P's < 0.05]. Based on 1 h intakes, saline preference was in- 
creased by DAGO, but the increases were not significant. 
Based on 2-h cumulative intakes, both doses significantly 
increased saline preference (25, 35 and 41% for the 0, 1 
and 3 nmol doses, respectively). A similar pattern was ob- 
served when preferences were based on 3-h cumulative in- 
takes. 
In non-deprived rats trained to drink either 0.6% saline 
or water, DAGO (1 and 3 nmol) caused increases in cumu- 
lative saline intake measured at 1, 2 and 3 h (Fig. 3). The 
mean intake of water in all three drug treatment conditions 
was negligible (less than 0.5 ml) and therefore was not ana- 
lyzed. Intakes were also increased in rats receiving the 1.7% 
saline solution (Fig. 3). In the control condition (saline in- 
jection), mean intakes of both water and 1.7% saline were 
less than 1.0 ml. A two-factor ANOVA (dose x fluid) indi- 
cated a significant effect of dose at 1, 2 and 3 h [F(2,14)= 
9.19, 12.41 and 13.37, all P~<0.05];  the fluid effect (water 
versus saline) and the dose x fluid interaction were not sig- 
nificant. Dunnett's tests indicated that the 1 nmol dose sig- 
nificantly increased water and saline intake at 1, 2 and 3 h; 
the 3 nmol dose increased cumulative water intake at 2 h 
and water and saline intake at 3 h. 
Discussion 
A number of studies have shown that opioid agonists and 
antagonists cause increases and decreases, respectively, in 
the preference for or intake of sweet-tasting fluids (LeMag- 
nen et al. 1980; Calcagnetti and Reid 1983; Cooper 1983; 
Siviy and Reid 1983; Czirr and Reid 1986; Lynch 1986). 
It has been suggested, therefore, that endogenous opioid 
peptides play a role in mediating the pleasureable or re- 
warding aspects of the tastes of these fluids (see Reid 1985; 
Cooper et al. 1988). There is evidence, however, that this 
postulated role for opioids may not be limited to sweet 
tastes. Cooper and Gilbert (1984) have shown that the an- 
tagonist naloxone causes a selective reduction in the intake 
of hypotonic saline solutions, while Bertino et at. (1988) 
found that morphine increased the intake of both isotonic 
and hypertonic saline solutions. The present results support 
and extend these findings by showing that similar results 
are obtained with central injections of naloxone and a selec- 
tive mu agonist. 
Non-deprived rats given placebo injections consumed 
negligible amounts of water and very little 0.6% saline. 
Central injections of the mu receptor agonist DAGO pro- 
duced significant increases in saline intake, while water in- 
take remained minimal. When non-deprived rats were given 
water and 1.7% saline, DAGO increased the intake of both 
fluids. In the non-deprived state, the taste of the salt solu- 
tions presumably provides the primary incentive to drink. 
Our finding that DAGO stimulated saline intake, then, is 
consistent with the hypothesis that opioids play a role in 
mediating the preference for palatable solutions. We have 
recently found that centrally administered DAGO produces 
a similar effect on the intake of a palatable saccharin solu- 
tion (0.15%) (Gosnell and Majchrzak 1989, in press). 
In non-deprived rats given water and 1.7% saline, it 
is possible that the observed water intake following DAGO 
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injections was secondary to intake of 1.7% saline, as it 
is well known that intubation of hypertonic saline elevates 
the intake of water (Stellar et al. 1954). As a test of whether 
DAGO would stimulate water intake when saline was not 
available, we performed a brief test utilizing rats from the 
non-deprived experiment. Test procedures were similar to 
those described above, except that only water was given, 
and rats were given injections of NaC1 (n = 3) or DAGO 
(3 nmol, n = 6) in a single trial. Following DAGO injections, 
mean cumulative water intakes at 1, 2 and 3 h were 
0.7+0.3, 1.4-t-0.4 and 1.7_0.3ml,  respectively. These 
values were not significantly different from those of NaC1- 
injected rats (0.8+_0.5 ml at 1, 2 and 3 h). This lack of 
effect supports the view that the observed water intake in 
experiment 3 was secondary to the ingestion of hypertonic 
saline. It is likely that with a more frequent measuring of 
intake, an increase in saline intake would be found to pre- 
cede increases in water intake. 
In water-deprived rats, the initial effects of DAGO on 
intake were dose dependent: the low dose (1 nmol) tended 
to increase saline intake, while the 3 nmol dose tended to 
decrease intake. It is probable that the decrease observed 
with the 3 nmol dose is due to motor impairment, as this 
dose initially produces catalepsy. Beyond the 1 st hour, both 
doses tended to increase saline intake. Water intake was 
slightly reduced by both doses, such that the percentage 
of total fluid taken as saline tended to increase. When the 
choice was between water and 1.7% saline, DAGO in- 
creased intake of 1.7% saline and slightly reduced or had 
no effect on water intake. These results resemble those of 
Bertilao et al. (1988), who found that systemic injections 
of  morphine increased imakes of 0.9 and 1.5% saline. 
Centrally administered naloxone (50 gg) reduced prefer- 
ence for 0.6% saline from 89% (control condition) to 74% 
(based on l-h intakes). Cooper and Gilbert (1984) reported 
a similar reduction following systemic injection of naloxone 
(10 mg/kg). As with our results, the reductions in preference 
were not statistically significant. However, in both cases, 
naloxone significantly reduced intake of 0.6% saline; water 
intake was low and was unaffected by naloxone. We ob- 
served an opposite pattern when rats were given water and 
1.7% saline. Naloxone significantly reduced water intake 
and caused a slight, delayed increase in 1.7% saline intake. 
Thus, regardless of which saline concentration was paired 
with water, the primary effect of naloxone was to reduce 
intake of the fluid consumed in the largest quantity. 
In contrast to the present results. Cooper and Gilbert 
(1984) found that systemically administered naloxone 
caused equivalent reductions of both water and 1.7% saline 
intake, such that preference was unchanged. Aside from 
the differences in route of naloxone administration, one 
possible explanation for the difference between their results 
and ours concerns baseline preference for 1.7% saline. With 
our procedures, preference for 1.7% saline was 15 20% 
in the naloxone trials and 25-27% in the DAGO trials. 
Cooper and Gilbert (1984) reported a preference of 43.9%, 
a value not significantly less than 50%. This difference in 
preference may be related to the duration of intake tests. 
We measured hourly intake for 3 h, whereas Cooper and 
Gilbert allowed a choice of fluids for only 15 min. 
It should be noted that 1.7% saline is not necessarily 
aversive to rats, even though hypertonic saline solutions 
are generally placed on the descending limb of a preference- 
aversion curve (Weiner and Stellar 1951 ; Stellar et al. 1953; 
Khavari 1970). Stellar et al. (1953) have shown that the 
descending limb of this curve for salt solutions is due largely 
to post-ingestive osmotic effects. When using a measure 
of taste reactivity which is independent of ingestion, Grill 
and Norgren (1978) found that sodium chloride as strong 
as 1.3 M (7.6%) elicited no rejection responses. Schwartz 
and Grill (1984) reported that hypertonic saline solutions 
elicit rejection responses only after prolonged oral infu- 
sions. They make a distinction between aversion and avoid- 
ance, and report that with short (1 min) oral infusions, hy- 
pertonic saline solutions elicit purely ingestive responses. 
Thus, while rats avoid hypertonic solutions, there is no 
unequivocal evidence that they are unpalatable. However, 
the palatability-enhancing effect of DAGO may be con- 
founded by the apparently aversive post-ingestive conse- 
quences of hypertonic saline. 
Although both naloxone and DAGO significantly in- 
creased the percentage of total intake consumed as 1.7% 
saline, their effects on the intakes of individual fluids were 
different. Following treatment with DAGO, 2-h cumulative 
saline intake was increased by 4.1 and 5.2 ml by the 1 and 
3 nmol doses, respectively, while mean water intakes 
changed by less than 1 ml for both doses. In naloxone- 
treated animals, there was a decrease in water intake and 
an increase in saline intake. The 20 and 50 ~tg doses de- 
creased 2-h cumulative water intake by 1.9 and 3.8 ml, re- 
pectively, and increased saline intake by 3.7 and 2.0 ml. 
That a significant increase in saline intake was not observed 
until the final measurement (3.25 h post-injection) suggests 
that this increase may not be a direct result of opioid block- 
ade. 
Relative to the magnitude of their respective baselines, 
DAGO- and naloxone-induced changes of intake in de- 
prived rats were generally small. It is possible that the depri- 
vation schedule was sufficiently severe to provoke near 
maximal drinking regardless of pharmacological manipula- 
tions. An additional factor which may have obscured or 
diminished the effects of DAGO and naloxone in the de- 
prived condition is the greater variability in intake observed 
in deprived versus non-deprived rats. Young and Falk 
(1956) have reported that compared to non-thirsty rats, 
thirsty rats show more individual differences in saline pref- 
erence, more indiscriminate behavior, and more mutations 
of preference. 
The intake and excretion of both water and sodium 
are prominent factors in the regulation of water balance. 
It is conceivable, then, that the observed behavioral re- 
sponses to the administration of naloxone and DAGO 
could represent compensatory behaviors for DAGO- or na- 
loxone-induced changes in the excretion of water and/or 
sodium. This appears unlikely, however, as naloxone has 
been reported to have no effect on urine flow or sodium 
or potassium excretion (Danesh and Walker 1988). Chronic 
treatment with the antagonist naltrexone was reported to 
reduce urine flow and sodium, potassium and total osmolar 
excretions, but these changes were attributed to a reduction 
in food and water intake, since water and electrolyte bal- 
ance were unchanged (Lang et aI. 1982). Central adminis- 
tration of morphine, an agonist primarily at mu receptors, 
decreased urine flow and sodium excretion (Danesh and 
Walker 1988). One would expect, therefore, that a compen- 
satory behavioral response to these effects of a m u  agonist 
would be a decrease in saline intake, rather than the ob- 
served increases. Thus, it is doubtful that changes in water 
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balance and/or electrolyte excretion underlie the effects re- 
ported here. 
Several lines of evidence suggest that central rather than 
peripheral opioid peptides and receptors are involved in 
the regulation of ingestion (see Sanger 1983; Gosnell 1986; 
Cooper et al. 1988). The effects of D A G O  in the present 
studies support a role for central opioid peptides and recep- 
tors in the control of saline preference as well. In the experi- 
ments with naloxone, however, a peripheral site of action 
cannot  be ruled out, as the doses injected are near the low 
end of the range of doses which have been reported to 
affect fluid intake or preference when injected systemically 
(20 and 50 gg equal approximately 0.07 and 0.17 mg/kg 
for a 300 g rat) (Cooper 1983; Cooper and Turkish 1983; 
Siviy and Reid 1983; Cooper and Gilbert 1984; Lynch 
1986). Additional studies with quaternary naloxone would 
be useful in confirming a central site of action for naloxone. 
In summary, central injections of the mu opioid agonist 
D A G O  caused selective increases in the intake of 0.6% 
saline, while injections of naloxone caused selective de- 
creases in intake of saline. When water and 1.7% saline 
were available, D A G O  selectively increased saline intake 
in deprived rats and increased consumption of both fluids 
in non-deprived rats. Naloxone significantly decreased 
water intake and caused a delayed increase in 1.7% saline 
intake. Post-ingestive osmotic effects are a potential con- 
found in interpreting the results of experiments utilizing 
hypertonic saline. Generally, these results support the sug- 
gestion that endogenous opioid peptides play a role in me- 
diating the preference for salt solutions. 
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